Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, LIFEMD, INC. reported revenue of $194M, up 25.3% year over year. Operating margin was -4.0% and net margin 7.4%, on a free-cash-flow margin of 3.3% with capital expenditure at 1.0% of revenue. Every figure is computed directly from LFMD's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $194M | -4.0% | 7.4% |
| FY2024 | $155M | -13.2% | -13.8% |
| FY2023 | $153M | -9.5% | -13.5% |
| FY2022 | $119M | -36.5% | -38.3% |
| FY2021 | $93M | -58.5% | -65.6% |
How does LFMD compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: AACG · ABSI · ACCS · ACHC · ACM · ADUS
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.